Literature DB >> 27780776

Physician Education on Controllable Costs Significantly Reduces Cost of Laparoscopic Hysterectomy.

Katherine Croft1, Patricia J Mattingly2, Patrick Bosse3, R Wendel Naumann4.   

Abstract

STUDY
OBJECTIVE: To determine whether educating surgeons about their controllable instrumentation costs by providing cost data on total laparoscopic hysterectomy (LH) would reduce the cost of this procedure.
DESIGN: Prospective cohort study (Canadian Task Force classification III).
SETTING: Academic-affiliated community hospital. PATIENTS: Patients who underwent LH between April 2014 and March 2015 with surgeons who performed at least 10 LHs during that time period, along with a second group who underwent LH with the same cohort of surgeons between July 2015 and September 2015. INTERVENTION: The cost of LH was calculated for all surgeons who performed more than 10 LHs between April 2014 and March 2015. Itemized cost data were collected. The individual costs, as well as a summary of the data, were shared with all of the physicians to highlight areas of potential cost savings. The costs were then measured for 3 months after the educational intervention (July-September 2015) to gauge the impact of physician cost education.
MEASUREMENTS AND MAIN RESULTS: Thirteen surgeons met the criteria for inclusion in this analysis. Together, they performed 271 hysterectomies, with an average instrumentation cost of $1539.47 ± $294.16 and an average operating room time of 178 ± 26 minutes. Bipolar instrument choice represented 37% of the baseline costs, followed by 10% for trocar, 9% for cuff closure, and 8% for uterine manipulator. This same group of surgeons performed a total of 69 hysterectomies in the 3-month follow-up period of July-September 2015, with an average instrumentation cost of $1282.62 ± $235.03 and an average operating room time of 163 ± 50 minutes. There was statistically significant cost reduction of $256.85 ± $190.69 (p = .022), with no significant change in operating room time. Bipolar instrument cost decreased significantly, by $130.02 ± $125.02 (p = .021), representing 51% of the total cost savings. Trocar, cuff closure, and uterine manipulator costs were not significant sources of cost savings on average, but did represent sources of cost savings for some surgeons individually.
CONCLUSION: Given adequate education about the products available for use in their institution, surgeons make informed decisions regarding the choice of instrumentation, allowing them to directly impact the cost of total LH, resulting in cost savings.
Copyright © 2016 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bipolar instruments; Cost analysis; Laparoscopic hysterectomy

Mesh:

Year:  2016        PMID: 27780776     DOI: 10.1016/j.jmig.2016.10.003

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  5 in total

1.  A multipurpose uterine/vaginal manipulator for laparoscopic urogynecologic procedures.

Authors:  Gabriel N Schaer; Dimitri Sarlos; Zaraq Khan
Journal:  Int Urogynecol J       Date:  2019-04-06       Impact factor: 2.894

2.  Effects of a Surgical Receipt Program on the Supply Costs of Five General Surgery Procedures.

Authors:  Beiqun Zhao; Griffin A Tyree; Timothy C Lin; Florin Vaida; Blake J Stock; Thomas A Hamelin; Bryan M Clary
Journal:  J Surg Res       Date:  2018-12-13       Impact factor: 2.192

3.  Evaluating Surgeons on Intraoperative Disposable Supply Costs: Details Matter.

Authors:  Christopher P Childers; Ira S Hofer; Drew S Cheng; Melinda Maggard-Gibbons
Journal:  J Gastrointest Surg       Date:  2018-08-10       Impact factor: 3.452

4.  Uterine manipulator in total laparoscopic hysterectomy: safety and usefulness.

Authors:  Yara Abdel Khalek; Roger Bitar; Costas Christoforou; Simone Garzon; Alessandro Tropea; Antonio Biondi; Zaki Sleiman
Journal:  Updates Surg       Date:  2019-10-12

5.  Surgical Equipment Price Awareness Amongst Obstetrician-Gynecologists.

Authors:  Kayvahn P Steck-Bayat; Janet A Foote; Jamal Mourad; Kelly H Roy; Andrea G Aguirre; Nichole D Mahnert
Journal:  JSLS       Date:  2019 Apr-Jun       Impact factor: 2.172

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.